Real-time · AI · Cross-signal
Discover the power of real-time signals plus AI
Every funding round, exec hire, M&A move, contract, and sentiment shift on Invizius — with verified, ICP-scored contact reveals (email + mobile) on demand.
Trusted by founders, sales teams, recruiters, and investors at firms like BlackRock, Oracle, Kleiner Perkins, and HubSpot.
Invizius raised £950,000 in a funding round led by Mercia Ventures to prepare for the next stage of clinical trials for its H-Guard dialysis treatment.
PRIVATESep 23, 2024•over 1 year ago
Amount Raised
£950,000
Round Type
series b
Investors
Scottish EnterpriseUniversity Of Edinburgh’s Old College CapitalSyensqoCalculus CapitalMercia Ventures
Description
Edinburgh-based biotech Invizius has secured £950,000 in funding led by Mercia Ventures. The investment will support the progression of clinical trials for H-Guard, a treatment addressing inflammatory responses during dialysis.
Related People
Suggested for you
1 contactSign in to view contact details
Funding Insights
Based on industry dataVC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech
Watching Invizius? See every signal — funding, hires, M&A, contracts, sentiment.
See plans